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A complex partnership between the host and the vast intestinal microbial ecosystem serves numerous
biological activities including nutrition, immunity, and barrier function. In this issue of Immunity, Singh
et al. (2014) demonstrate that microbial-derived butyrate mediated its protective activity against inflam-
mation and colorectal cancer through GPR109a signaling.From birth to adulthood, humans progres-
sively acquire andmaintain a complex mi-
crobial ecosystem at various body sites
and cavities. Early on, these microorgan-
isms establish a complex relationship
with the host, resulting in the modulation
of several biological functions. A prime
example of such a relationship is the in-
testine, where trillions of microorganisms
influence nutritional and immunological
functions. Understanding and decipher-
ing the dialog occurring between the mi-
crobiota and the intestine at homeostasis
as well as during disease states has been
the subject of intense investigation. From
a metabolic standpoint, the microbiome
operates at an organ level, extracting en-
ergy and nutrients and generating
numerous and important by-products
from the diet, all of which benefit bacterial
communities (adaptation, growth, main-
tenance), but most importantly assure
essential host homeostatic function
(Nicholson et al., 2012). For example, die-
tary fibers and nondigestible carbohy-
drates (starch, cellulose, fructans, xylans,
inulin) are processed by various microbial
enzymatic systems to produce diverse
beneficial compounds such as essential
vitamins (vitamin K, biotin, cobalamin,
riboflavin, and niacin) and short chain fatty
acids (SCFA) such as propionate, acetate,
and butyrate (Nicholson et al., 2012).
However, microbial disturbances as iden-
tified in patients with inflammatory bowel
diseases (IBD) and colorectal cancer
(CRC) bring changes to the ‘‘functional’’
aspect of the microbiome, among them
the depletion of butyrate-producing
bacteria (Guzman et al., 2013). Butyrate
not only represents a primary source
of energy for intestinal epithelial cells
(IECs) but also modulates host immune8 Immunity 40, January 16, 2014 ª2014 Elsevresponse, thereby acting as a key micro-
bial metabolite for intestinal homeostasis.
Various G protein-coupled receptors
(Gpr) such as Gpr41, Gpr43, and
Grp109a mediate SCFA activities, but
the molecular and cellular events respon-
sible for butyrate-mediated beneficial ef-
fects in the intestine are still unclear. In
this issue, Singh et al. (2014) provide key
evidence that bacterial-derived butyrate
and dietary fibers attenuate intestinal
inflammation and CRC development
through Gpr109a-mediated T regulatory
(Treg) cell differentiation (Figure 1). The
study shows how diet, microbiota, and
immune cells form an intricate communi-
cation network essential for the mainte-
nance of intestinal homeostasis.
How could the microbiota and associ-
ated metabolites exert a protective role
in the intestine? Singh et al. (2014) first
observed that Foxp3+ (Treg) cell number
and frequency in the lamina propria of
Grp109a/ mice were significantly lower
than in WT mice, a profile matching
impaired immunosuppressive IL-10
secretion and enhanced production of
proinflammatory IL-17. This inflammatory
intestinal phenotype may be the conse-
quence of defective tolerogenic instruc-
tion provided by mononuclear cells.
Indeed, when Singh et al. (2014) coincu-
bated colonic macrophages and DCs
from Grp109a/ mice with naive CD4+
T cells obtained from OT-II TCR trans-
genic mice, they noticed that these
mononuclear cells were unable to induce
Treg cell differentiation compared to
their WT counterpart. The fact that
butyrate-treated splenic DCs and macro-
phages from Grp109a/ mice failed to
release both IL-10 and class 1A aldehyde
dehydrogenase (Aldh1a) and to promoteier Inc.a Treg cell phenotype (high IL-10, low
IL-17) in a coculture assay clearly shows
the key role of the receptor in mediating
butyrate immune response. Moreover,
niacin, which is also a Gpr109a ligand
and bacterial-derived product, repro-
duces butyrate effect on DC, macro-
phage, and Treg cell activities. This
highlights the central role of Gpr109a
in capturing and processing signaling
generated by microbial-derived metabo-
lites. Antibiotic treatment causes massive
perturbation in microbial ecosystems,
and loss of microbial entities with con-
current decreased biochemical activities
(metabolites) are bound to influence
intestinal immune regulation. Singh et al.
(2014) observed that niacin supplemen-
tation restores the number of Treg cells
depleted by antibiotic treatment of WT
mice, an effect nullified in Gpr109a/
mice. These findings demonstrate that
Gpr109a is essential for mucosal immu-
noregulatory functions afforded by the
microbial metabolite butyrate.
Disrupting the dialog between micro-
biota and the host, especially at the level
of mucosal immunology, is expected to
have profound effects on disease devel-
opment. By using the AOM+DSS model
of colitis-associated CRC, Singh et al.
(2014) showed that development of
inflammation and CRC are exacerbated
in Grp109a/ mice compared to WT
mice, a phenomenon associated with
defective production of colonic IL-10
and cytoprotective IL-18 and heightened
level of IL-17. The authors also observed
a similar increased tumorigenesis
when ApcMin/+ mice were crossed to
Gpr109a/ mice, showing that the
impact of Gpr109a on cancer is not















Figure 1. Interplay between Diet,
Microbiome, and Gpr109a in the Intestine
Microbiota-derived enzymatic activities generate
metabolites such as butyrate and niacin from die-
tary fibers. Butyrate and niacin engage Gpr109a
presents on intestinal epithelial cells, dendritic
cells, and macrophages triggering production of
cytoprotective IL-18, immunoregulatory IL-10,
and class 1A aldehyde dehydrogenase (Aldh1a).
This environment (IL-10, Aldh1a) favors the devel-
opment of T regulatory cells (Treg) from naive
T cells, while repressing generation of proinflam-
matory Th17 cells, thereby preventing conditions
leading to the development of colitis and colitis-
associated colorectal cancer.
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marrow transfer studies, Singh et al.
(2014) showed that the contribution
of radio-resistant cells to Gpr109a-
mediated anticarcinogenic effect is
greater than the one afforded by immune
cells. The fact that IL-18 administrationdecreased tumorigenesis in Grp109a/
mice suggests that a complex network
of immunoregulatory molecules (IL-10,
Aldh1, IL-18) from various cellular
sources (immune cells, epithelial cells?)
participate in intestinal homeostasis
(Figure 1).
The importance of the microbiota
in Gpr109a-mediated protective effect is
clearly demonstrated in antibiotic-treated
WT mice, which displayed enhanced
AOM+DSS-induced tumorigenesis com-
pared to untreated mice. Administration
of niacin to antibiotic-treated mice was
able to decrease tumor development, an
effect not observed in Grp109a/ mice.
Remarkably, the antibiotic experiment
also indicates that the microbiota not
only protects against tumorigenesis as
seen in WT mice, but also promotes
CRC inGrp109a/mice. This deleterious
effect was associated with expansion of
bacteria belonging to the Prevotellaceae
family and TM7 phylum, although the
events leading to these microbial compo-
sitional changes were not established.
To clearly link microbial-derived
metabolites (byturate and niacin) with
Gpr109a-mediated protective function,
the authors fed ApcMin/+ mice with either
a normal chow containing fiber or a
fiber-free diet. As opposed to wide-spec-
trum antibiotic treatment, which elimi-
nates virtually all bacteria, dietary fiber
manipulation has a more targeted
effect on the biota, essentially regulating
the capacity of bacteria to generate
SCFA. Remarkably, fiber-free diet en-
hanced tumorigenesis in ApcMin/+ mice,
a phenomenon strongly attenuated by
niacin supplementation. Grp109a/
mice failed to show a similar response
to dietary fiber manipulation or niacin
supplementation, providing strong evi-
dence that the protective effect is
mediated by this receptor. A recent
report showed that butyrylated diet
also promotes Treg cell development
and prevented T-cell-adoptive-transfer-
mediated chronic colitis (Furusawa
et al., 2013), lending support to the
key role of bacteria in promoting an
homeostatic phenotype regardless of the
initial insult (chemical or naive T cell
transfer).
The current study adds an important
piece to the complex jigsaw puzzle
formed by diet, microbiota, and immune
cells interaction in the intestine andImmunitybrings new understanding regarding the
intricate communication network neces-
sary for the maintenance of intestinal
homeostasis. Although compelling and
informative, the study also raised ques-
tions. It is striking to note that other
SCFA receptors such as GPR41 and
GPR43 are not able to compensate for
the lack of Gpr109a, although butyrate
binds both receptor types and elicits a
Treg-cell-associated anti-inflammatory
response (Smith et al., 2013). Comparing
inflammation and CRC susceptibility be-
tween GPR43-deficient and Gpr109a/
mice would help understand the poten-
tially divergent role of these receptors
in mediating intestinal homeostasis.
Furthermore, the cell type (epithelial cells,
immune cells) responding to SCFA expo-
sure may also dictate the extent of
the protective response. This is clearly
demonstrated in immune-cell-derived
GPR43 signaling, which mediates an
anti-inflammatory response (Maslowski
et al., 2009), whereas IEC-derived
GPR43 signaling appears to promote an
inflammatory phenotype in the DSS
model of colitis (Kim et al., 2013). Note-
worthy, a recent report showed that
butyrate-mediated expansion of Treg
cells is Gpr109a independent, suggesting
a complex impact of this SCFA on im-
mune cell behaviors (Arpaia et al., 2013).
A careful genetic dissection of the cellular
compartment (DCs, myeloid cells, epi-
thelial cells) responsible for Gpr109a-
mediated protective effect would be
necessary to fully capture the essence
of the cellular network responding to
microbial cues in the intestine.
Antibiotic treatment suggests that
cancer-promoting bacteria arise from
the biome of Grp109a/ mice. How
does the lack of Gpr109a signaling lead
to expansion of potentially cancer-pro-
moting bacteria? Is this phenomenon
related to improper development of
intestinal Treg cells? Biome with cancer-
promoting and cancer-protecting func-
tion seems to coexist and factors (host
genetics, diet, etc.) altering this balance
would probably have functional conse-
quence for the host (Schwabe and Jobin,
2013). Future studies would be required
to address these issues.
The intestinal mucosa is bombarded
by signals derived from the magma of
bacteria and bacterial products pre-
sent in the intestinal environment. This40, January 16, 2014 ª2014 Elsevier Inc. 9
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is unlikely to elicit a uniform response
from the gut. For example, the microbial
structural component polysaccharide
A present on Bacteroides fragilis contrib-
utes to intestinal homeostasis by promot-
ing differentiation of Foxp3+ Treg cells
(Round and Mazmanian, 2010), whereas
segmented filamentous bacterium (SFB)
favors the differentiation of CD4+ T helper
cells into Th17 cells, a more proinflam-
matory phenotype (Ivanov et al., 2009).
Similarly, as reported here and in other
studies, microbial-derived metabolites
(SCFA) also trigger an immune response
from the host. How are these numerous
and disparate microbial cues (structural
products, metabolites, etc.) integrated
into a cohesive and coordinate response
by the host? This dichotomy between
the deleterious and protecting function
of the microbiota and associated microbi-
al products clearly illustrate challenges
facing researchers working on this com-10 Immunity 40, January 16, 2014 ª2014 Elsplex system. Regardless, manipulating
host immune response by altering micro-
bial composition and activities through
dietary intervention and/or specific host
receptors could represent a powerful
mean to promote and/or maintain intes-
tinal homeostasis. Understanding the
various elements implicated in the com-
plex dialog between bacteria and the
host holds much promise for pathologies
such as IBD and CRC.REFERENCES
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The connection between inflammation, autoimmunity, and atherosclerosis is long established. In this issue of
Immunity, Lim et al. (2014) demonstrate that oxidized low-density lipoprotein is one of the key environmental
factors driving the development of inflammatory T helper 17 cells in atherosclerosis.Atherosclerosis is the major culprit in
cardiovascular disease and results from
a complex interaction between a hyper-
cholesterolemic state and chronically
inflamed blood vessels. The contribution
of inflammation to the pathophysiology
of atherosclerosis is well recognized
and became widely accepted after
the 1999 publication of the poignantly
titled ‘‘Atherosclerosis—An Inflammatory
Disease,’’ an influential commentary in
the New England Journal of Medicine by
Ross Russel (Ross, 1999). Indeed, eventhe so-called fatty streaks detected in
infants and children—the first evidence
of vascular injury—are characteristically
inflamed and composed of monocyte-
derived macrophages and T lympho-
cytes. These early and asymptomatic
lesions are mainly lipid-laden macro-
phages (foam cells) with some T cells,
but if the inflammatory response con-
tinues unabated, a mature and complex
plaque rich in activated immune cells will
form and become prone to rupture and
thrombosis (Hansson, 2005). People withautoimmune diseases, such as rheuma-
toid arthritis (RA) and systemic lupus ery-
thematosus (SLE), are significantly more
likely to develop cardiovascular diseases
(Kahlenberg and Kaplan, 2013). Interest-
ingly, elevated CD4+ T helper 17 (Th17)
cells, which produce proinflammatory
interleukin-17A (IL-17A), not only are
associated with these autoimmune dis-
eases but have also been identified in
atherosclerotic lesions (Eid et al., 2009;
Erbel et al., 2009; Hansson, 2005).
Thus, Th17 cells and increased IL-17A
